Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-07

Clinical Trial Update: COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III [Phase 3]

View source ↗

Summary

Phase 3 trial assessing dexamethasone for COVID-19-associated ARDS was terminated. The study evaluated dexamethasone treatment in patients with coronavirus infe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Hospital Sirio-Libanes | Conditions: Coronavirus Infection, Pneumonia, Viral | Phase 3 | Status: TERMINATED